International Business

Magazine articles on conducting multinational business and trade.

Old Articles: <Older 2201-2210 Newer>

Chemistry World November 1, 2012 Andrew Turley	Novartis biotech plant for Singapore The new plant, which will make drugs through cell culture, will be located with the Novartis production plant at Tuas.
Chemistry World October 31, 2012 Andrew Turley	Bayer spends $1.2bn on supplement maker German healthcare giant Bayer has struck a deal to buy Schiff Nutrition, a US company specializing in vitamins and nutritional supplements, for $1.2 billion.
HBS Working Knowledge October 29, 2012 Dina Gerdeman	Are You Paying a Tip -- or a Bribe? New research shows that there's actually a fine line between the socially acceptable act of tipping and the immoral act of bribing. In the business world, corporate executives should be careful.
HBS Working Knowledge October 25, 2012 Julia Hanna	Developing the Global Leader What skills do today's executives need to develop to become effective global leaders of tomorrow? And how do corporations teach these skills to their own leaders?
HBS Working Knowledge October 22, 2012 Michael Blanding	Not Your Father's Communist-Run Capitalism The face of state-owned companies in Russia, China, and other countries has changed dramatically over the last several decades, says professor Aldo Musacchio. What capitalists need to know about these increasingly powerful competitors.
Chemistry World October 17, 2012 Andrew Turley	Carbon dioxide to chemical partnership State-owned Malaysian oil company Petronas will partner will New Zealand firm LanzaTech, which specializes in making fuels and chemicals from industrial waste gases, such as carbon monoxide, by fermentation.
Pharmaceutical Executive October 1, 2012 Nicolas Pechet	Your Local Competitor: A Threat in Emerging Markets? Pharmaceutical companies looking to wrest market share in high growth markets of tomorrow must overcome challenges from a new crop of national champions.
Financial Advisor October 2012 Jerilyn Klein Bier	Beyond The BRICs Investors see compelling opportunities in the next four largest growth markets. Equity funds dedicated to the MIST markets (Mexico, Indonesia, South Korea and Turkey) took in a net fund flow of $786 million during the six weeks ending August 31.
Chemistry World October 2, 2012 Andrew Turley	Merck & Co $460m ion channel deal Merck & Co has struck a $460 million deal for rights to certain drug candidates developed by Belgian pharma company Ablynx. Merck will get rights to the monoclonal antibodies found to target a voltage gated ion channel.
Chemistry World September 26, 2012 Andrew Turley	Boehringer drops virology R&D German pharma company Boehringer Ingelheim is to close its R&D site in Laval, Canada, in early 2013, with the loss of 170 jobs.
<Older 2201-2210 Newer> Return to current articles.